Over 20 years’ experience of working on cell and gene therapies in academic and industry roles with expertise in manufacturing of viral vectors and cell therapies.
Served as Vice President of Manufacturing for publicly traded Rocket Pharmaceuticals, and prior to that as Senior Director of Process Development and Commercialization for publicly traded WuXi AppTec, where he was responsible for manufacturing operations and program management for gene therapy clients.
Previously ran autologous cell therapy clinical trials for Cook Medical, and held key positions for cell and gene therapy core programs at Indiana University School of Medicine. Co-developed ultra-high throughput microinjection device (US9885059) and co-founded Basilard Biotech to commercialize this technology.
Holds a Ph.D. in Cellular and Molecular Pathology from Vanderbilt University School of Medicine and was a Children’s Brittle Bone Foundation fellow during a post-doctoral fellowship at Case Western Reserve University School of Medicine.